EC Number   |
Natural Substrates |
|---|
   3.1.1.47 | 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
- |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
enzyme from red blood cells is not involved in the degradation of platelet-activating factor accumulated in blood |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
inactivation of platelet-activating factor, up-regulation of enzyme by pioglitazone reduces cell elongation |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
regulation of platelet-activating factor |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
regulation of platelet-activating factor, anti apoptotic protein |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
regulation of platelet-activating factor, anti-inflammatory enzyme |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
regulation of platelet-activating factor, enzyme could play an important role in the development or down regulation of inflammation in acute respiratory distress syndrome |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
regulation of platelet-activating factor, essential for epithelial morphogenesis |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
regulation of platelet-activating factor, important role in inflammation and in atherosclerotic processes related to the metabolic syndrome |
| 3.1.1.47 | 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O |
regulation of platelet-activating factor, protection against toxic effects of platelet-activating factor |
